Application of demethylwedelolactone-7-sulfate in preparation of anti-pulmonary fibrosis drug
A technology of norwerethrin and pulmonary fibrosis, which can be applied in the directions of drug combination, active ingredients of heterocyclic compounds, respiratory system diseases, etc., can solve the problems of ineffective effect of pulmonary fibrosis and the like, and achieve the effect of good intervention effect.
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- Publication Date
- 2014-07-16
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to a new use of the compound norwedelolide-7-sulfate as a medicine for treating pulmonary fibrosis. Background technique
[0002] Pulmonary fibrosis is a progressive disease characterized by fibrosis and lung parenchymal remodeling. Pulmonary fibroblasts hyperproliferate, transdifferentiate into myofibroblasts, secrete a large amount of collagen and deposit matrix. There is no effective treatment. Bleomycin-induced pulmonary fibrosis animal model is the most commonly used. Intratracheal administration of bleomycin causes tissue inflammation and fibrosis within a short period of time, and bleomycin causes upregulation of pro-inflammatory cytokines such as IL-1 and TNF-α, followed by an increase in pro-fibrotic markers such as TGF-β1 , Fibronectin, and α-SMA expression reached the highest value at 14 days. The bleomycin animal model began to show fibrosis symptoms 9 days after modeling, and typical fibrosis symptoms appeared on 2...
Examples
Embodiment Construction
[0017] 1. Preparation and structure confirmation of norwedelide 7-sulfate
[0018] Herba Ecliptae (Herba Ecliptae) is the dry aerial part of Eclipta prostrate L., a plant of Compositae, purchased from Bozhou, Anhui. Reagents such as ethanol and petroleum ether were of analytical grade. Dry the aboveground part of Eclipta chinensis, extract 3 times with 80% ethanol 10 times the volume of crude drug, 2 hours each time, filter, combine the extracts, remove ethanol under reduced pressure to obtain 903g of total extract, petroleum ether, ethyl acetate in turn , n-butanol equivalent extraction, and the n-butanol extract was concentrated under reduced pressure by silica gel (150-200 mesh) column chromatography, eluted with chloroform-methanol-water (5:3:0.1), Sephadex LH-20 chromatographic column Purified, and eluted with chloroform-methanol (1:1) to obtain the compound demethylwedelolactone-7-sulfate (Demethylwedelolctone-7-sulfate).
[0019] Spectral data and its structure are as...